Acromegaly  >>  Januvia (sitagliptin)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Januvia (sitagliptin) / Merck (MSD)
NCT02060383 / 2012-002916-16: Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly

Completed
4
249
US, Europe, RoW
Pasireotide s.c., SOM230, Sitagliptin, Liraglutide, Insulin, Pasireotide LAR, Metformin
Novartis Pharmaceuticals
Cushing's Disease, Acromegaly
02/18
03/18
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Januvia (sitagliptin) / Merck (MSD)
NCT02060383 / 2012-002916-16: Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly

Completed
4
249
US, Europe, RoW
Pasireotide s.c., SOM230, Sitagliptin, Liraglutide, Insulin, Pasireotide LAR, Metformin
Novartis Pharmaceuticals
Cushing's Disease, Acromegaly
02/18
03/18

Download Options